Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-05-24
1997-01-14
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530329, A61K 3800, C07K 700, C07K 706
Patent
active
055939660
ABSTRACT:
Peptide derivatives with inhibitory activity on the enzyme systems involved in the oxidative burst of human phagocytic cells comprise six and seven amino acid peptide sequences from human cytochrome b.sub.558. The derivatives may be used in medicaments for the treatment of inflammatory diseases.
REFERENCES:
Royer-Pokora, et al, "Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location", Nature, vol. 322, beginning at p. 32, 1986.
Pember, et al., "Cytochrome b.sub.558 from (Bovine) Ganulocytes" vol. 259, J. Biol. Chem. pp. 10590-10595, 1984.
Lutter, et al., "Purification and Partial Characterization of the b-type Cytochrome from Human Polymorphonuclear Leukocytes", J. Biol. Chem. vol. 260 (4) pp. 2237-2244, 1985.
Parko's et al, "Purified Cytochrome b from Human Granulocyte Plasma Membrane is comprised of two polypeptide with Relative Molecular Weights of 91,000 and 22,000".
J. Clinc. Invest, vol. 80, pp. 732-742.
Iizuka et al. "Pyridine and Imidazole Reversibly inhibit the Respiratory Burst of Porcine and Human Neutrophils" Biochem and Biophysic Res Comm. vol. 130 (2) pp. 621-626.
Kleinberg, et al, "Glycosylation of Cytochrome b.sub.558 Large Subunit Varies in Different Human Phagocytic Cells", vol. 143, pp. 4152-4157, 1989.
Yamaguchi, et al., "Purification and some Properties of the Small Subunit of Cytochrome b.sub.558 from Neutrophils", J. Biol. Chem., vol. 261 (1) pp. 112-118, 1989.
Verhoeven et al, "Characterization of two monoclonal antibodies against Cytochrome b.sub.558 of Human Neutrophils" Blood vol. 73, (6) pp. 1686-1694, 1989.
Rotrosen, et al, J. Biol. Chem. vol. 265, No. 32, pp. 1910-19915, 1990.
Levy, et al, Biochem and Biophysc Res. Comm vol. 170, 3, 1114-11120.
Rotrosen et al, J. Biol. Chem, vol. 265, 15, pp. 8745-8750, 1990.
Kleinberg, et al, Biochemistry 31, pp. 2686-2690, 1992.
Kleinberg, et al, J. Biol. Chem vol. 265, 26, pp. 15577-15583, 1990.
Grynkiewicz, et al, J. Biol. Chem, vol. 260, pp. 3440-3450 1989.
Rostrosen, et al, I "A cytoplasmic carboxyterminal . . . " Clin. Res. vol. 36, No. 3, 1988.
Rostrosen et al II "Evidence for interaction . . . ," Clin. Res. vol. 37, No. 2, 1989.
Royer-Pokora, et al, "Cloning the gene for an inherited human disorder, . . . ", Nature 322:32, 1986
Malech Harry L.
Rotrosen Daniel
Marshall S. G.
The United States of America as represented by the Department of
Weimar Elizabeth C.
LandOfFree
Peptide derivatives of cytochrome b.sub.558 and their use as med does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide derivatives of cytochrome b.sub.558 and their use as med, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide derivatives of cytochrome b.sub.558 and their use as med will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388188